WO2009063508A2 - Nanoparticle composition and process thereof - Google Patents
Nanoparticle composition and process thereof Download PDFInfo
- Publication number
- WO2009063508A2 WO2009063508A2 PCT/IN2008/000771 IN2008000771W WO2009063508A2 WO 2009063508 A2 WO2009063508 A2 WO 2009063508A2 IN 2008000771 W IN2008000771 W IN 2008000771W WO 2009063508 A2 WO2009063508 A2 WO 2009063508A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- silver
- cellulose
- nanoparticle composition
- reducing agent
- metal salt
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 72
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims description 49
- 230000008569 process Effects 0.000 title description 6
- 229920002678 cellulose Polymers 0.000 claims abstract description 83
- 239000001913 cellulose Substances 0.000 claims abstract description 83
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 61
- 239000004332 silver Substances 0.000 claims abstract description 51
- 229910052709 silver Inorganic materials 0.000 claims abstract description 50
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims abstract description 48
- 239000002121 nanofiber Substances 0.000 claims abstract description 43
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 36
- 239000000463 material Substances 0.000 claims abstract description 35
- 238000002360 preparation method Methods 0.000 claims abstract description 28
- 239000002184 metal Substances 0.000 claims description 46
- 229910052751 metal Inorganic materials 0.000 claims description 44
- 239000003638 chemical reducing agent Substances 0.000 claims description 39
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 38
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- 229920003043 Cellulose fiber Polymers 0.000 claims description 22
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000012279 sodium borohydride Substances 0.000 claims description 19
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 19
- 239000012266 salt solution Substances 0.000 claims description 17
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000001509 sodium citrate Substances 0.000 claims description 9
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 9
- 235000019263 trisodium citrate Nutrition 0.000 claims description 9
- 229940038773 trisodium citrate Drugs 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 4
- 229910001958 silver carbonate Inorganic materials 0.000 claims description 4
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 claims description 4
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 2
- 239000007943 implant Substances 0.000 claims description 2
- 238000007885 magnetic separation Methods 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 238000012634 optical imaging Methods 0.000 claims description 2
- 238000000527 sonication Methods 0.000 claims description 2
- 229910001923 silver oxide Inorganic materials 0.000 abstract description 2
- 239000002114 nanocomposite Substances 0.000 description 33
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 28
- 229940124024 weight reducing agent Drugs 0.000 description 27
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 26
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 18
- 239000000123 paper Substances 0.000 description 18
- 239000002131 composite material Substances 0.000 description 13
- 230000001580 bacterial effect Effects 0.000 description 11
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 241000191967 Staphylococcus aureus Species 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 230000000845 anti-microbial effect Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 229920002749 Bacterial cellulose Polymers 0.000 description 7
- 239000005016 bacterial cellulose Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000002776 aggregation Effects 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000000445 field-emission scanning electron microscopy Methods 0.000 description 5
- -1 Ag+ ions Chemical class 0.000 description 4
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 4
- 238000003917 TEM image Methods 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 229920001046 Nanocellulose Polymers 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- 238000004627 transmission electron microscopy Methods 0.000 description 3
- 244000235858 Acetobacter xylinum Species 0.000 description 2
- 235000002837 Acetobacter xylinum Nutrition 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 238000011203 antimicrobial therapy Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 239000011258 core-shell material Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000000349 field-emission scanning electron micrograph Methods 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000013580 millipore water Substances 0.000 description 2
- 229940031182 nanoparticles iron oxide Drugs 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000008104 plant cellulose Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000007102 tryptic soy broth medium Substances 0.000 description 2
- 239000006150 trypticase soy agar Substances 0.000 description 2
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N CuO Inorganic materials [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical class C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 238000004847 absorption spectroscopy Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WSSMOXHYUFMBLS-UHFFFAOYSA-L iron dichloride tetrahydrate Chemical compound O.O.O.O.[Cl-].[Cl-].[Fe+2] WSSMOXHYUFMBLS-UHFFFAOYSA-L 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000012785 packaging film Substances 0.000 description 1
- 229920006280 packaging film Polymers 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000003094 perturbing effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910052950 sphalerite Inorganic materials 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/32—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond
- D06M11/36—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond with oxides, hydroxides or mixed oxides; with salts derived from anions with an amphoteric element-oxygen bond
- D06M11/49—Oxides or hydroxides of elements of Groups 8, 9,10 or 18 of the Periodic Table; Ferrates; Cobaltates; Nickelates; Ruthenates; Osmates; Rhodates; Iridates; Palladates; Platinates
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/83—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with metals; with metal-generating compounds, e.g. metal carbonyls; Reduction of metal compounds on textiles
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
- D06M23/08—Processes in which the treating agent is applied in powder or granular form
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/63—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/63—Inorganic compounds
- D21H17/66—Salts, e.g. alums
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
- D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
- D21H21/36—Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
- D21H21/50—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by form
- D21H21/52—Additives of definite length or shape
Definitions
- the present invention relates to nanoparticle composition comprising cellulose nanof ⁇ bers embedded with nanosized material. More particularly the present invention relates to cellulose nanofibers embedded with silver or iron oxide embedded silver. In addition the present invention is also related to the preparation of the cellulose nanofibers embedded with nanosized material.
- Nanoparticles of silver, MgO, ZnO, Fe 3 O 4 , ZnS, CuO and SnO 2 have assumed great importance in view of their application in biomedical and bio technology, pollution abatement, biosensor technology and as agents of antimicrobial therapy.
- Several ways and means have been pioneered in the recent past, particularly, towards the production of nanoparticles of various metals individually and in combination.
- Nanosilver is spectacular owing to its antimicrobial activity useful in the process of reducing microbial contamination in the field of food processing and hygiene control.
- use of less toxic or non-toxic chemicals has always been preferred in the form of reducing agents and stabilizers as chemically green procedures are preferred over conventional synthesis.
- Microorganisms cause mild to severe infections in human beings, animals and plants.
- silver is a well known broad-spectrum agent employed most extensively since ancient times to fight infections caused by bacteria, yeast, fungi as well as virus.
- Nanosilver is known to inhibit or inactivate microorganisms effectively with lower toxicity to tissue. Due to the large surface area and high reactivity nanosilver is endowed with remarkable antimicrobial property. Because of long lasting biocidalaction nanosilver preparations are currently being used as antimicrobial agents in several industries such as ceramics, paper, plastic and packing films.
- Cellulose is a biopolymer mostly produced by plants and micro-organisms, however some marine animals were also shown to produce cellulose. Though wood is the major source of plant cellulose its separation and purification is a tedious process with the intervention of toxic chemical, hence, its large-scale application in pure form is impracticable.
- Bacterial cellulose produced by Acetobacter xylinum (Gluconacetobacter xylinus) is an attractive biomaterial with its intrinsic nanostructural hierarchy, its purity, mechanical strength and chemical robustness. This bacterium produces extracellular cellulose under static culture condition in the form of highly reticulated net like structure along with the entrapped bacteria, media components and protein. The whole complex is referred to as pellicle.
- the cellulose is purified using alkali treatment at boiling temperature.
- a novel antimicrobial composite material comprising of bacterial cellulose and nanosilver.
- Several researchers have reported the use of plant cellulose in the preparation of antibacterial silver formulations.
- the process is simple and scalable for its real-time applications in various fields such as food packaging and in antimicrobial therapy.
- the principal object of the present invention is to develop nanoparticle composition comprising cellulose nanofibers embedded with nanosized material.
- Yet another object of the present invention is to develop a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material.
- Yet another object of the present, invention is to use the composition comprising cellulose nanofibers embedded with nanosized material in the manufacture of antibacterial medicament.
- the present invention provides a nanoparticle composition comprising cellulose nanofibers embedded with nanosized material; a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: mixing metal salt solution with cellulose nanofibers and adding reducing agent to the mixture to reduce the silver salt to obtain said nanoparticles composition wherein the nanosized material is metal; a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material wherein the nanosized material is iron oxide embedded metal, said method comprising steps of: adding metal salt solution to a mixture of cellulose nanofibers and iron oxide, reducing metal salt using reducing agent, separating the silver embedded iron oxide on cellulose nanofibers, washing with water followed by drying to obtain said nanoparticles composition and a method of preparation of nanoparticles composition comprising cellulose nanofibers embedded with nanosized material wherein the cellulose fibers is in paper form and the nanosized material is metal, said method comprising steps of: soaking cellulose papers in metal salt solution, washing the
- Figure 1 UV-visible absorption spectra of silver loaded cellulose nanocomposites obtained via reduction of silver nitrate by using (i) hydrazine and (ii) sodium borohydride for (a) untreated and (b) NaOH treated cellulose fibers, respectively.
- Figure 2 UV-visible absorption spectra of silver loaded cellulose nanocomposites obtained via reduction of silver nitrate by using (i) glucose, (ii) ethylene glycol, (iii) tri- sodium citrate and (iv) hydroxylammonium hydrochloride for (a) untreated and (b) NaOH treated cellulose fibers, respectively.
- Figure 3 FE-SEM images of cellulose fibers (a) and silver loaded cellulose fiber nanocomposite obtained via reduction of silver nitrate by using (b) hydrazine and (c) sodium borohydride, respectively.
- the insets show the images at higher magnifications.
- Figure 4 Antibacterial efficacy of (a) sodium borohydride reduced, (b) hydrazine reduced and (c) hydrazine reduced and NaOH treated silver loaded cellulose fiber nanocomposite and of (d) sodium borohydride reduced and (e) hydrazine reduced cellulose paper silver nanocomposite, respectively.
- Figure 5 TEM image of effected bacterial cell by cellulose Ag nanocomposite. The insets (a) shows the detaching of the outer membrane from inner cytoplasmic membrane by Ag nps, (b) shows the penetration of Ag nps inside the bacterial cell and (c) shows electron light region in bacterial cell.
- Figure 6 TEM images of (a) ⁇ - Fe 2 O 3 @ Ag for (88.9 % Fe + 11.1 % Ag). The inset shows these particles at higher magnification.
- Figure 7 UV-Vis absorption spectra of Fe 3 O 4 @ Ag (solid lines), Ag sol (dash line) and Fe 3 O 4 (dotted lines) nanoparticles, respectively.
- Figure 8 Antibacterial inhibition of cellulose nano fiber and iron oxide embedded silver nano particle composite obtained by using hydrazine as the reducing agent.
- the present invention is in relation to nanoparticle composition comprising cellulose nanofibers embedded with nanosized material.
- the cellulose fibers are in the form of paper.
- the nanosized material is selected from a group comprising metal and iron oxide embedded metal.
- the metal is silver.
- the iron oxide is selected from a group comprising Fe 3 O 4 , 7-Fe 2 O 3 , preferably Fe 3 O 4 .
- the silver is sourced from a group comprising silver nitrate, silver chloride, silver carbonate, preferably silver nitrate or any combination thereof.
- the nanoparticles composition is antibacterial in nature.
- the present invention is also in relation to a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: a) Mixing metal salt solution with cellulose nanofibers; and b) adding reducing agent to the mixture to reduce the metal salt to obtain said nanoparticles composition.
- the nanosized material is a metal.
- the metal salt solution and cellulose nanofibers are mixed by sonication for about 30 min.
- the present invention is also in relation to a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: a) adding metal salt solution to a mixture of cellulose nanofibers and iron oxide; b) reducing metal salt using reducing agent; c) separating the silver embedded iron oxide on cellulose nanofibers; and d) washing with water followed by drying to obtain said nanoparticles composition.
- the nanosized material is iron oxide embedded metal
- the silver embedded iron oxide on cellulose nanofibers are separated by magnetic separation.
- the present invention is also in relation to a method of preparation of nanoparticles composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: a) soaking cellulose papers in metal salt solution; b) washing the soaked cellulose paper; c) soaking the washed cellulose papers in solution of reducing agent; d) washing the cellulose papers of step c; and e) drying to obtain said nanoparticles composition.
- the cellulose fiber is in the paper form.
- the nanosized material is a metal.
- the cellulose papers are soaked in metal salt solution for about 30 min.
- the metal salt solution is about
- the cellulose papers are washed with mixture ethanol and water, wherein the concentration of ethanol ranges from about
- the reducing agent is selected from a group comprising hydrazanium hydroxide and sodium borohydride.
- the drying is carried out at a temperature ranging from about 20 0 C to a temperature of about 30 0 C preferably 25°
- the metal is silver.
- the metal salt is selected from a group comprising silver nitrate, silver chloride, silver carbonate preferably silver nitrate or combination thereof.
- the metal salt solution is prepared by dissolving metal salt in water.
- the reducing agent is added dropwise with constant stirring to the mixture.
- the reducing agent is selected from a group comprising hydrazanium hydroxide, sodium borohydride, hydroxyl ammonium hydrochloride and tri-sodium citrate, preferably hydrazanium hydroxide.
- the preparation of nanoparticle composition is carried out at a temperature ranging from about 20 0 C to a temperature of about 30 0 C preferably 25 0 C, when the reducing agent is hydrazanium hydroxide.
- the preparation of nanoparticle composition is carried out at a temperature ranging from about 20 °C to a temperature of about 30 0 C preferably 25 0 C, when the reducing agent is sodium borohydride. In still another embodiment of the present invention, the preparation of nanoparticle composition is carried out at a temperature ranging from about 20 0 C to a temperature of about 30 0 C preferably 25 0 C, when the reducing agent is tri-sodium citrate. In still another embodiment of the present invention, the preparation of nanoparticle composition is carried out at a temperature ranging from about 20 0 C to a temperature of about 30 0 C preferably 25 0 C, when the reducing agent is hydroxyl ammonium hydrochloride.
- the preparation of nanoparticle composition is carried out by maintaining about ImM alkalinity by adding sodium hydroxide solution when the reducing agent is hydroxyl ammonium hydrochloride.
- the present invention is also in relation to the use of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material in the manufacture of antibacterial medicament.
- the medicament is used in food packaging, clothing, medical applications, face masks, laundry detergent and air filters.
- the medical applications is selected from a group comprising wound coverings, dressings, bandages, biological implants, and diagnostic biomedical optical imaging.
- the nanoparticle composition is non-toxic and free from side effects.
- Nanosilver Antimicrobial activity of nanosilver is very broad against various microorganisms and it is of great significance because of its ability to inhibit the growth or inactivate microorganisms such as fungi, algae, bacteria, yeast and virus.
- UV-visible absorption spectroscopy, energy dispersive X-ray spectroscopy (EDAX), Transmission electron microscopy (TEM) and Field emission- scanning electron microscopy (FE-SEM) were used to characterize the composite.
- the composite material had shown remarkable stability without aggregation of silver nanoparticles with the nanocellulose functioning as capping agent conformed using the
- the nanocomposite obtained through the use of hydrazine showed optimum growth inhibition against Staphyloccus aureus the ones prepared using sodium borohydride as reducing agent.
- the NaOH treated nanocellulose showed further enhancement in the antibacterial activity of the nanocomposite, which is rather attributed to its higher swelling characteristic, and retention of hydrogel property. It was also noticed that these composites not only inhibit the bacterial growth but also works as bactericidal at very low concentration of silver (110 ⁇ g ml "1 ). Due to its high antibacterial activity, and stabilizing effect of bacterial cellulose matrix, the nanocomposite appears to be promising for its application in biomedical technology, in antimicrobial textile and in food processing industry.
- FIG. 1 shows the UV-visible absorption spectrum of the silver loaded cellulose nanocomposite obtained by using hydrazine and sodium borohydride and the corresponding spectrum for the remaining reducing agents; glucose, ethylene glycol, tri-sodium citrate and hydroxyl ammonium hydrochloride are shown in Fig. 2.
- the bare cellulose does not show any absorption in the UV-visible region and the silver loaded composite shows a strong absorption in the UV-visible region due to surface plasmon resonance (SPR) of silver nanoparticles.
- SPR surface plasmon resonance
- the collective oscillation of free electrons in metallic nanoparticles known as SPR appears in the UV-visible region.
- the position and broadening of SPR depends on the shape, size, and stabilizing agent and on the dielectric constant of the medium.
- the absorption maximum of SPR observed is illustrated in Table 1.
- the observed SPR is red shifted in comparison to their corresponding sol (citrate or borohydride reduced sol) and is attributed to dipole resonance interactions between nanoparticles, a well known phenomena in noble metal nanoparticles.
- Fig. 3a, b and c show the FE-SEM images of the cellulose fibers and silver loaded fibers obtained by using hydrazine and sodium borohydride, respectively.
- the mean diameter of the particles is roughly 82 ⁇ 34 and 100 + 14 nm for hydrazine and sodium borohydride reduced nanocomposite, respectively.
- the image display uniform network structure with the silver nanoparticles is observed to be distributed homogeneously on the cellulose surfaces as individual, nonaggregated particles.
- the images reveal that the particles are strongly adhered to the cellulose fibers. This adherence helps in stabilizing and in immobilizing the silver nanoparticles and thus preventing from agglomeration.
- the surface functional groups of cellulose fiber are the reason for the strong interaction of silver nanoparticles. This is one of the major advantages of the present protocol where other foreign chemicals, surfactant or polymer are not necessary to stabilize silver nanoparticles.
- the images also reveal that the cellulose fibers are not damaged during the synthesis.
- Nanosilver After obtaining the robust nanostructures their practical application in bacterial inhibition is examined.
- the antibacterial activity of nanosilver is mainly attributed to its affinity towards biologically important functional groups such as sulfhydryl amino, imidazole, carboxyl and phosphate groups, which exist mainly in protein such as enzymes.
- Nanosilver is also known to interact with DNA resulting in the formation of pyramidine dimers preventing its replication.
- the antibacterial activity of nanocomposite was considerably higher against the indicator pathogen Staphylococcus aureus as evidenced by the inhibitory zone (Fig. 4).
- the inhibition zone was around 2.6 cm radius in tryptic soya agar in the presence of NaOH treated cellulose.
- the nanocomposites prepared using non-swollen (no alkali treatment involved) was comparatively less inhibitory (2.0 cm radius).
- the antibacterial effect of silver nanocomposite on stationary phase cells of Staphylococcus aureus was investigated using TEM (Fig. 5).
- nanocomposite was shown to lyse the bacterial cells of stationary phase by way of perturbing the bacterial cell wall and consequent entry into the cell protoplasm causing leakage of cell contents and plasmolysis as seen in the TEM images (Fig. 5).
- the amount of silver in 50 ⁇ l composite was calculated to be around 5.4 ⁇ g, which is considerably low and more over a remarkable inhibitory zone was shown in the study in comparison to the earlier investigations.
- nanocomposite will be a suitable antibacterial material for incorporation in to polymers to be made as films to control the growth of microorganisms in areas such as food processing textiles and other health care domains.
- the antibacterial activity of nano composite was remarkable against Staphylococcus aureus where as it was less inhibitory towards E. coli and S. typhi, when tested.
- nanoparticles when formed in a solution are capped by an organic layer and same is the case of the iron oxide nanoparticles as well as iron oxide embedded silver nano particles (see Fig. 6). These nanoparticles show their characteristic UV visible spectra as shown in Fig. 7. Due to the presence of a strong capping agent the surface effects of silver are not similar to pristine silver surface. In the case of nanocomposites of cellulose nano fibers and iron oxide embedded silver nanoparticles, the capping agent is the cellulose nano fibers itself. Since the cellulose fibers do not form a complete cover on silver surface, the silver surface behaves more like pristine silver surface. The cellulose nano fibers also releases the nanoparticles in a controlled fashion into the solution.
- a silver nanocomposite comprising of nanoparticulate bacterial cellulose and nanosilver was prepared in aqueous phase.
- the stabilization of the nanoparticles was achieved by the presence of water-dispersed cellulose particles in the reaction medium.
- the antibacterial activity had matched to a very larger extent with SPR.
- the optimal antibacterial activity was noticed in the composite which was prepared using hydrazine as reductant.
- the nanocomposite had inhibited the S. aureus during the growth process and bacterial cells in their stationery phase.
- the composite materials and the route of synthesis appear to be suitable for application in the preparation of antimicrobial food packaging films, water purification systems, medical dressings, inner textiles. Modifications need to be carried out to incorporate the nanocomposite into polymeric films for their optimum utilization.
- the utility of the material can be widened by exploring additional fictionalization.
- Table 1 UV-visible absorption, pH and antibacterial characteristics of cellulose Ag composite obtained by using different reducing- agents.
- Silver nanoparticles loading on cellulose fibers In order to synthesize cellulose fibers silver nanocomposites we have used a range of reducing agents hydrazanium hydroxide, sodium borohydride, hydroxyl ammonium hydrochloride, tri-sodium citrate, D-glucose and ethylene glycol to reduce Ag + to silver nanoparticles. Weighed quantities of cellulose sample ⁇ 1 % (w/w) is dispersed in ImM aqueous silver nitrate solution in a beaker and sonicated for half an hour. Aqueous solution of the reducing agents ⁇ 2-5 mM are added drop wise to the cellulose solution.
- the reactions are carried out at room temperature except in the case of sodium borohydride where ice- cold condition is maintained and in case of D-glucose, tri-sodium citrate and ethylene glycol, the solution is refluxed for an hour.
- sodium borohydride where ice- cold condition is maintained and in case of D-glucose, tri-sodium citrate and ethylene glycol, the solution is refluxed for an hour.
- hydroxyl ammonium hydrochloride as reducing agent 1 mM alkalinity is maintained by adding aqueous NaOH solution.
- Silver nanoparticles loading on cellulose papers In order to load silver nanoparticles on cellulose papers, the paper is soaked in ImM aqueous silver nitrate solution for half an hour, washed with ethanol and water again soaked in ImM aqueous solutions of reducing agent (hydrazanium hydroxide or sodium borohydride) for half an hour. Finally they were washed with ethanol and water and dried in air at room temperature (-22 0 C).
- reducing agent hydrogenazanium hydroxide or sodium borohydride
- Lambda 900 UV/VIS/NIR spectrophotometer Lambda 900 UV/VIS/NIR spectrophotometer. Transmission electron microscopy (TEM) experiments were performed using JEOL 3010 with an operating voltage of 300 keV. Field Emission Scanning Electron Microscopy (FE-SEM) was done by using a Nova 600 NanoSEM (FEI, Germany). The composition mainly carbon, oxygen and silver of silver loaded cellulose were determined by using EDAX equipped to the FE- SEM. The pH measurements were done by using a Eutech p H 510. All the measurements were performed at room temperature ( ⁇ 22 0 C).
- TEM Transmission electron microscopy
- FE-SEM Field Emission Scanning Electron Microscopy
- the composition mainly carbon, oxygen and silver of silver loaded cellulose were determined by using EDAX equipped to the FE- SEM.
- the pH measurements were done by using a Eutech p H 510. All the measurements were performed at room temperature ( ⁇ 22 0 C).
- Assay for antibacterial activity of silver nanocomposite The antibacterial activity of silver-cellulose nanocomposite was tested using Staphylococcus aureus. A fresh culture of the bacterium was prepared by inoculating a loop of inoculum into 50 ml of nutrient broth and BHI broth. The organism was monitored as 25% glycerol store in broth and was stored at 85 0 C. After incubating the culture at 37 0 C for 15-20 hrs, serial dilution in the range 10 '1 - 10 3 was made in 2 ml eppendorf tubes with sterile distilled water. Tryptic soy agar plates were prepared by adding 7.5g of tryptic soy broth medium and 0.2g of agar in 250ml of distilled water.
- Rasayan 35-38%
- NaOH Merck, 97%)
- HNO 3 Labeloratory Rasayan, 69-72 %)
- Rhodamine B (SD fine chemicals, India, 80%) were used without further purification.
- 1 % aqueous solution of AgNO 3 is added to the solution to make appropriate concentration OfAg + in the solutions.
- Five set of concentrations, 10 "4 , 5 x 10 "4 , 10 “4 , 5 x 10 ⁇ 3 and 10 "2 M each for Ag + was done.
- 0.2 M aqueous solution of hydrazanium hydroxide is added drop wise with constant shaking.
- the final concentration of hydrazanium hydroxide is maintained two times higher than Ag + .
- the solution turns to yellowish green for Ag.
- the particles are separated by using a magnet and washed 2-3 times with distilled water and finally they were dried under vacuum at room temperature for further characterization.
- Fe 3 U 4 core and silver shell (core-shell) nanoparticles loading on cellulose fibers In order to synthesize cellulose fibers core-shell nanocomposites we have mixed the nanoparticles of Fe 3 O 4 with cellulose fibers and reduced the silver on to the iron oxide nanoparticles as described in the earlier section.
- TEM Transmission electron microscopy
- JEOL 3010 with an operating voltage of 300 keV.
- Uv-Vis absorption measurements were done by using a Perkin-Elmer Lambda 900 UV/VIS/NIR spectrophotometer.
- the molar ratios of Fe to Ag were determined by EDAX measurements.
- Magnetization measurements were performed using a VSM in PPMS (Physical property measurement system) with magnetic fields up to 20 kOe at 298.15 K.
- Assay for antibacterial activity of silver nanocomposite The antibacterial activity of core-shell-cellulose nanocomposite was tested using Staphylococcus aureus. A fresh culture of the bacterium was prepared by inoculating a loop of inoculum into 50 ml of nutrient broth and BHI broth. The organism was monitored as 25% glycerol store in broth and was stored at 85 0 C. After incubating the culture at 37 0 C for 15-20 hrs, serial dilution in the range 10 "1 - 10 3 was made in 2 ml eppendorf tubes with sterile distilled water.
- Tryptic soy agar plates were prepared by adding 7.5g of tryptic soy broth medium and 0.2g of agar in 250ml of distilled water. After autoclaving at 20 psi for 15 minutes the molter was poured into disposal petriplates at the rate of 15 ml / dish. After solidification of the medium under aseptific conditions 100 ⁇ l of 10 "3 dilution
- Staphylococcus aureus culture was spread into each plate with a glass spreader. Wells were made with the help of a 7 mm cylindrical metal pipe. At the center of the well 50 ⁇ l of silver nanocomposite in solution form was placed. The petridishes were kept at 5
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Textile Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Abstract
The present invention relates to nanoparticle composition comprising cellulose nanofibers embedded with nanosized material. More particularly the present invention relates to cellulose nanofibers embedded with silver or iron oxide embedded silver. In addition the present invention is also related to the preparation of the cellulose nanofibers embedded with nanosized material. The nanoparticle composition is antibacterial in nature and can be utilized in various antibacterial applications.
Description
NANOPARTICLE COMPOSITION AND PROCESS THEREOF
Field of invention:
The present invention relates to nanoparticle composition comprising cellulose nanofϊbers embedded with nanosized material. More particularly the present invention relates to cellulose nanofibers embedded with silver or iron oxide embedded silver. In addition the present invention is also related to the preparation of the cellulose nanofibers embedded with nanosized material.
Background of the invention and Prior art:
Nanoparticles of silver, MgO, ZnO, Fe3O4, ZnS, CuO and SnO2 have assumed great importance in view of their application in biomedical and bio technology, pollution abatement, biosensor technology and as agents of antimicrobial therapy. Several ways and means have been pioneered in the recent past, particularly, towards the production of nanoparticles of various metals individually and in combination. Nanosilver is fascinating owing to its antimicrobial activity useful in the process of reducing microbial contamination in the field of food processing and hygiene control. In the production of nanoparticles use of less toxic or non-toxic chemicals has always been preferred in the form of reducing agents and stabilizers as chemically green procedures are preferred over conventional synthesis.
Microorganisms cause mild to severe infections in human beings, animals and plants. Among the inorganic antimicrobial agents silver is a well known broad-spectrum agent employed most extensively since ancient times to fight infections caused by bacteria, yeast, fungi as well as virus. Nanosilver is known to inhibit or inactivate microorganisms effectively with lower toxicity to tissue. Due to the large surface area and high reactivity nanosilver is endowed with remarkable antimicrobial property. Because of long lasting biocidalaction nanosilver preparations are currently being used as antimicrobial agents in several industries such as ceramics, paper, plastic and packing films.
Cellulose is a biopolymer mostly produced by plants and micro-organisms, however some marine animals were also shown to produce cellulose. Though wood is the major
source of plant cellulose its separation and purification is a tedious process with the intervention of toxic chemical, hence, its large-scale application in pure form is impracticable. Bacterial cellulose produced by Acetobacter xylinum (Gluconacetobacter xylinus) is an attractive biomaterial with its intrinsic nanostructural hierarchy, its purity, mechanical strength and chemical robustness. This bacterium produces extracellular cellulose under static culture condition in the form of highly reticulated net like structure along with the entrapped bacteria, media components and protein. The whole complex is referred to as pellicle. The cellulose is purified using alkali treatment at boiling temperature. In the present investigation we have attempted to develop a novel antimicrobial composite material comprising of bacterial cellulose and nanosilver. Several researchers have reported the use of plant cellulose in the preparation of antibacterial silver formulations. We report the preparation of silver nanoparticles embedded into nanopafticulate bacterial cellulose as stabilizer for effective inhibition of Staphylococcus aureus. The process is simple and scalable for its real-time applications in various fields such as food packaging and in antimicrobial therapy.
Objects of the Invention:
The principal object of the present invention is to develop nanoparticle composition comprising cellulose nanofibers embedded with nanosized material. Yet another object of the present invention is to develop a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material.
Yet another object of the present, invention is to use the composition comprising cellulose nanofibers embedded with nanosized material in the manufacture of antibacterial medicament.
Statement of invention:
Accordingly, the present invention provides a nanoparticle composition comprising cellulose nanofibers embedded with nanosized material; a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: mixing metal salt solution with cellulose
nanofibers and adding reducing agent to the mixture to reduce the silver salt to obtain said nanoparticles composition wherein the nanosized material is metal; a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material wherein the nanosized material is iron oxide embedded metal,, said method comprising steps of: adding metal salt solution to a mixture of cellulose nanofibers and iron oxide, reducing metal salt using reducing agent, separating the silver embedded iron oxide on cellulose nanofibers, washing with water followed by drying to obtain said nanoparticles composition and a method of preparation of nanoparticles composition comprising cellulose nanofibers embedded with nanosized material wherein the cellulose fibers is in paper form and the nanosized material is metal, said method comprising steps of: soaking cellulose papers in metal salt solution, washing the soaked cellulose paper, soaking the washed cellulose papers in solution of reducing agent, washing the cellulose papers and drying to obtain said nanoparticles composition.
Description of Figures:
Figure 1: UV-visible absorption spectra of silver loaded cellulose nanocomposites obtained via reduction of silver nitrate by using (i) hydrazine and (ii) sodium borohydride for (a) untreated and (b) NaOH treated cellulose fibers, respectively. Figure 2: UV-visible absorption spectra of silver loaded cellulose nanocomposites obtained via reduction of silver nitrate by using (i) glucose, (ii) ethylene glycol, (iii) tri- sodium citrate and (iv) hydroxylammonium hydrochloride for (a) untreated and (b) NaOH treated cellulose fibers, respectively.
Figure 3: FE-SEM images of cellulose fibers (a) and silver loaded cellulose fiber nanocomposite obtained via reduction of silver nitrate by using (b) hydrazine and (c) sodium borohydride, respectively. The insets show the images at higher magnifications.
Figure 4: Antibacterial efficacy of (a) sodium borohydride reduced, (b) hydrazine reduced and (c) hydrazine reduced and NaOH treated silver loaded cellulose fiber nanocomposite and of (d) sodium borohydride reduced and (e) hydrazine reduced cellulose paper silver nanocomposite, respectively.
Figure 5: TEM image of effected bacterial cell by cellulose Ag nanocomposite. The insets (a) shows the detaching of the outer membrane from inner cytoplasmic membrane by Ag nps, (b) shows the penetration of Ag nps inside the bacterial cell and (c) shows electron light region in bacterial cell.
Figure 6: TEM images of (a) γ - Fe2O3 @ Ag for (88.9 % Fe + 11.1 % Ag). The inset shows these particles at higher magnification.
Figure 7: UV-Vis absorption spectra of Fe3O4 @ Ag (solid lines), Ag sol (dash line) and Fe3O4 (dotted lines) nanoparticles, respectively.
Figure 8: Antibacterial inhibition of cellulose nano fiber and iron oxide embedded silver nano particle composite obtained by using hydrazine as the reducing agent.
Figure 9: Control antibacterial efficacy of bacterial cellulose nano fiber with sodium borohydride and hydrazine against Staphylococcus aureus. Both the experiments show no antimicrobial activity against the bacterium.
Detailed description of invention:
The present invention is in relation to nanoparticle composition comprising cellulose nanofibers embedded with nanosized material.
In another embodiment of the invention, the cellulose fibers are in the form of paper.
In yet another embodiment of the invention, the nanosized material is selected from a group comprising metal and iron oxide embedded metal.
In still another embodiment of the present invention, the metal is silver.
In still another embodiment of the present invention, the iron oxide is selected from a group comprising Fe3O4, 7-Fe2O3, preferably Fe3O4.
In still another embodiment of the present invention, the silver is sourced from a group comprising silver nitrate, silver chloride, silver carbonate, preferably silver nitrate or any combination thereof.
In still another embodiment of the present invention, the nanoparticles composition is antibacterial in nature.
The present invention is also in relation to a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of:
a) Mixing metal salt solution with cellulose nanofibers; and b) adding reducing agent to the mixture to reduce the metal salt to obtain said nanoparticles composition.
In another embodiment of the invention, the nanosized material is a metal. In yet another embodiment of the invention, the metal salt solution and cellulose nanofibers are mixed by sonication for about 30 min.
The present invention is also in relation to a method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: a) adding metal salt solution to a mixture of cellulose nanofibers and iron oxide; b) reducing metal salt using reducing agent; c) separating the silver embedded iron oxide on cellulose nanofibers; and d) washing with water followed by drying to obtain said nanoparticles composition.
In another embodiment of the invention, the nanosized material is iron oxide embedded metal
In still another embodiment of the invention, the silver embedded iron oxide on cellulose nanofibers are separated by magnetic separation.
The present invention is also in relation to a method of preparation of nanoparticles composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: a) soaking cellulose papers in metal salt solution; b) washing the soaked cellulose paper; c) soaking the washed cellulose papers in solution of reducing agent; d) washing the cellulose papers of step c; and e) drying to obtain said nanoparticles composition.
In another embodiment of the invention, the cellulose fiber is in the paper form.
In yet another embodiment of the present invention, the nanosized material is a metal.
In still another embodiment of the present invention, the cellulose papers are soaked in metal salt solution for about 30 min.
In still another embodiment of the present invention, the metal salt solution is about
1 mM solution in concentration. In still another embodiment of the present invention, the cellulose papers are washed with mixture ethanol and water, wherein the concentration of ethanol ranges from about
75% to about 85%
In still another embodiment of the present invention, the reducing agent is selected from a group comprising hydrazanium hydroxide and sodium borohydride. In still another embodiment of the present invention, the drying is carried out at a temperature ranging from about 20 0C to a temperature of about 30 0C preferably 25°
C.
In still another embodiment of the present invention, the metal is silver.
In still another embodiment of the present invention, the metal salt is selected from a group comprising silver nitrate, silver chloride, silver carbonate preferably silver nitrate or combination thereof.
In still another embodiment of the present invention, the metal salt solution is prepared by dissolving metal salt in water.
In still another embodiment of the present invention, the reducing agent is added dropwise with constant stirring to the mixture.
In still another embodiment of the present invention, the reducing agent is selected from a group comprising hydrazanium hydroxide, sodium borohydride, hydroxyl ammonium hydrochloride and tri-sodium citrate, preferably hydrazanium hydroxide.
In still another embodiment of the present invention, the preparation of nanoparticle composition is carried out at a temperature ranging from about 20 0C to a temperature of about 30 0C preferably 25 0C, when the reducing agent is hydrazanium hydroxide.
In still another embodiment of the present invention, the preparation of nanoparticle composition is carried out at a temperature ranging from about 20 °C to a temperature of about 30 0C preferably 25 0C, when the reducing agent is sodium borohydride. In still another embodiment of the present invention, the preparation of nanoparticle composition is carried out at a temperature ranging from about 20 0C to a temperature of about 30 0C preferably 25 0C, when the reducing agent is tri-sodium citrate.
In still another embodiment of the present invention, the preparation of nanoparticle composition is carried out at a temperature ranging from about 20 0C to a temperature of about 30 0C preferably 25 0C, when the reducing agent is hydroxyl ammonium hydrochloride.
In still another embodiment of the present invention, the preparation of nanoparticle composition is carried out by maintaining about ImM alkalinity by adding sodium hydroxide solution when the reducing agent is hydroxyl ammonium hydrochloride.
The present invention is also in relation to the use of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material in the manufacture of antibacterial medicament.
In another embodiment of the present invention, the medicament is used in food packaging, clothing, medical applications, face masks, laundry detergent and air filters. In yet another embodiment of the present invention, the medical applications is selected from a group comprising wound coverings, dressings, bandages, biological implants, and diagnostic biomedical optical imaging.
In still another embodiment of the present invention, the nanoparticle composition is non-toxic and free from side effects.
Antimicrobial activity of nanosilver is very broad against various microorganisms and it is of great significance because of its ability to inhibit the growth or inactivate microorganisms such as fungi, algae, bacteria, yeast and virus. In this paper we report the synthesis and anti-bacterial activity of nanosilver stabilized with bacterial nanocellulose matrix. UV-visible absorption spectroscopy, energy dispersive X-ray spectroscopy (EDAX), Transmission electron microscopy (TEM) and Field emission- scanning electron microscopy (FE-SEM) were used to characterize the composite. The composite material had shown remarkable stability without aggregation of silver nanoparticles with the nanocellulose functioning as capping agent conformed using the
FE-SEM. The antibacterial activity of the nanocomposite was assessed against
Staphyloccus aureus. The nanocomposite obtained through the use of hydrazine showed optimum growth inhibition against Staphyloccus aureus the ones prepared
using sodium borohydride as reducing agent. The NaOH treated nanocellulose showed further enhancement in the antibacterial activity of the nanocomposite, which is rather attributed to its higher swelling characteristic, and retention of hydrogel property. It was also noticed that these composites not only inhibit the bacterial growth but also works as bactericidal at very low concentration of silver (110 μg ml"1). Due to its high antibacterial activity, and stabilizing effect of bacterial cellulose matrix, the nanocomposite appears to be promising for its application in biomedical technology, in antimicrobial textile and in food processing industry.
On addition of silver nitrate to the aqueous cellulose fiber, the fibers are randomly distributed and swelled. Due to the presence of large number of terminal hydrophilic
* hydroxyl -OH groups on the membrane of the cellulose fibers, Ag+ ions get easily deposited on the membrane and subsequently they can be reduced. The reduction of Ag+ in the cellulose silver nitrate aqueous mixture was performed by using a set of reducing agents as illustrated in Table 1.
The use of water as a solvent in the synthesis of silver nanoparticles causes an immediate agglomeration due to the high polarity of water. In the synthesis of nanoparticles stabilizers such as polyvinylpyrrolidone (PVP), ethylene glycol, various other biopolymers and citrate have been reported. In the present study we employed bacterial cellulose in the form of a nanoparticulate gel. The cellulose was found to protect the nanosilver formed from aggregation or coalescence by steric hindrance. To optimize the concentration as well as the size of the silver nanoparticles, the concentration of Ag+ was kept at 1 mM, since higher concentration results in comparatively larger particles with lower antimicrobial efficacy. We have tested that the inhibition is due to the silver nanoparticles and not because of the presence of residual chemicals such as the by-products of reducing agents. In addition, high concentrations of silver would render toxicity to animal cells. High concentration of silver may also favor aggregation. The pH, which is also a paramount controlling parameter of the nanoparticles size as well as the antibacterial activity, is monitored and listed in Table 1. The synthesized cellulose nanocomposites were found to be stable at least over a period of 3 months in aqueous form at room temperature with no indication of aggregation or discoloration and with no detectable loss of silver nano particles.
The formation of Ag nanoparticles was confirmed by UV-visible absorption spectra and Fe-SEM imaging. Fig. 1 shows the UV-visible absorption spectrum of the silver loaded cellulose nanocomposite obtained by using hydrazine and sodium borohydride and the corresponding spectrum for the remaining reducing agents; glucose, ethylene glycol, tri-sodium citrate and hydroxyl ammonium hydrochloride are shown in Fig. 2. The bare cellulose does not show any absorption in the UV-visible region and the silver loaded composite shows a strong absorption in the UV-visible region due to surface plasmon resonance (SPR) of silver nanoparticles. The collective oscillation of free electrons in metallic nanoparticles known as SPR appears in the UV-visible region. The position and broadening of SPR depends on the shape, size, and stabilizing agent and on the dielectric constant of the medium. The absorption maximum of SPR observed is illustrated in Table 1. The observed SPR is red shifted in comparison to their corresponding sol (citrate or borohydride reduced sol) and is attributed to dipole resonance interactions between nanoparticles, a well known phenomena in noble metal nanoparticles.
Fig. 3a, b and c show the FE-SEM images of the cellulose fibers and silver loaded fibers obtained by using hydrazine and sodium borohydride, respectively. The mean diameter of the particles is roughly 82 ± 34 and 100 + 14 nm for hydrazine and sodium borohydride reduced nanocomposite, respectively. The image display uniform network structure with the silver nanoparticles is observed to be distributed homogeneously on the cellulose surfaces as individual, nonaggregated particles. The images reveal that the particles are strongly adhered to the cellulose fibers. This adherence helps in stabilizing and in immobilizing the silver nanoparticles and thus preventing from agglomeration. The surface functional groups of cellulose fiber are the reason for the strong interaction of silver nanoparticles. This is one of the major advantages of the present protocol where other foreign chemicals, surfactant or polymer are not necessary to stabilize silver nanoparticles. The images also reveal that the cellulose fibers are not damaged during the synthesis.
After obtaining the robust nanostructures their practical application in bacterial inhibition is examined. The antibacterial activity of nanosilver is mainly attributed to its affinity towards biologically important functional groups such as sulfhydryl amino,
imidazole, carboxyl and phosphate groups, which exist mainly in protein such as enzymes. Nanosilver is also known to interact with DNA resulting in the formation of pyramidine dimers preventing its replication.
The antibacterial activity of nanocomposite was considerably higher against the indicator pathogen Staphylococcus aureus as evidenced by the inhibitory zone (Fig. 4). The inhibition zone was around 2.6 cm radius in tryptic soya agar in the presence of NaOH treated cellulose. The nanocomposites prepared using non-swollen (no alkali treatment involved) was comparatively less inhibitory (2.0 cm radius). In addition the antibacterial effect of silver nanocomposite on stationary phase cells of Staphylococcus aureus was investigated using TEM (Fig. 5). Further the nanocomposite was shown to lyse the bacterial cells of stationary phase by way of perturbing the bacterial cell wall and consequent entry into the cell protoplasm causing leakage of cell contents and plasmolysis as seen in the TEM images (Fig. 5). The amount of silver in 50 μl composite was calculated to be around 5.4 μg, which is considerably low and more over a remarkable inhibitory zone was shown in the study in comparison to the earlier investigations. We report the biocidal effect of silver nano-particles during growth and after cessation of growth of the pathogen. It was also found that washing of nano composite with distilled water deprive of its antibacterial activity to a great extent. Based on the data the nanocomposite will be a suitable antibacterial material for incorporation in to polymers to be made as films to control the growth of microorganisms in areas such as food processing textiles and other health care domains. The antibacterial activity of nano composite was remarkable against Staphylococcus aureus where as it was less inhibitory towards E. coli and S. typhi, when tested.
From Table 1 it is evident that the antibacterial activity of the silver nanoparticles is in congruence with the SPR of the composites. The nanoparticles with SPR at the blue end have shown a better antibacterial activity than those with red SPR. The size of the silver nanoparticles showed a linear relationship with SPR and hence smaller particles with larger surface area were found to show better interaction with bacterial surface and thereby bactericidal effect.
Iron oxide embedded silver nanoparticles have the magnetic characteristics of iron oxide and the surface properties of silver nanoparticles. This is a major advantage, since separation of the particle under the influence of magnetic field is possible. Most of these nanoparticles when formed in a solution are capped by an organic layer and same is the case of the iron oxide nanoparticles as well as iron oxide embedded silver nano particles (see Fig. 6). These nanoparticles show their characteristic UV visible spectra as shown in Fig. 7. Due to the presence of a strong capping agent the surface effects of silver are not similar to pristine silver surface. In the case of nanocomposites of cellulose nano fibers and iron oxide embedded silver nanoparticles, the capping agent is the cellulose nano fibers itself. Since the cellulose fibers do not form a complete cover on silver surface, the silver surface behaves more like pristine silver surface. The cellulose nano fibers also releases the nanoparticles in a controlled fashion into the solution. This is true in the case of nanocomposites of cellulose nano fibers and silver nanoparticles. The antibacterial effects of composite of cellulose nano fiber with iron oxide embedded silver nanoparticle is shown in Fig. 8 and is comparable to the pure silver case shown in Fig. 4. The magnetic property of iron oxide embedded silver nanoparticle could be used to remove these nanoparticles from its environment, where it could probably have toxic effects of silver, by applying an external magnetic field.
As a control experiment to show that the reducing agents like hydrazine and sodium borohydrate as well as the cellulose nano fibers do not show any antibacterial activity, we have tested the mixture of these in an antibacterial test culture and the results are displayed in Fig. 9. It is clear that these do not have any effect on the bacterial growth and their presence in the composite will not influence the observed results.
In conclusion a silver nanocomposite comprising of nanoparticulate bacterial cellulose and nanosilver was prepared in aqueous phase. The stabilization of the nanoparticles was achieved by the presence of water-dispersed cellulose particles in the reaction medium. The antibacterial activity had matched to a very larger extent with SPR. The optimal antibacterial activity was noticed in the composite which was prepared using hydrazine as reductant. The nanocomposite had inhibited the S. aureus during the growth process and bacterial cells in their stationery phase. The composite materials
and the route of synthesis appear to be suitable for application in the preparation of antimicrobial food packaging films, water purification systems, medical dressings, inner textiles. Modifications need to be carried out to incorporate the nanocomposite into polymeric films for their optimum utilization. The utility of the material can be widened by exploring additional fictionalization.
Table 1: UV-visible absorption, pH and antibacterial characteristics of cellulose Ag composite obtained by using different reducing- agents.
Chemicals: All the chemicals silver nitrate (Qualigens, 99.8%), hydroxonium hydroxide (Merck, 100%), sodium borohydride (Merck, > 95%), hydroxyl ammonium hydrochloride (Merck, > 98%), D-glucose (Qualigens, > 99%), ethylene glycol (Laboratory Rasayan, > 99%), tri-sodium citrate (x, > y%), sodium hydroxide (Merck, > 97%) was used without further purification. Millipore water was used for all washing procedures as well as solutions preparation.
Silver nanoparticles loading on cellulose fibers: In order to synthesize cellulose fibers silver nanocomposites we have used a range of reducing agents hydrazanium hydroxide, sodium borohydride, hydroxyl ammonium hydrochloride, tri-sodium citrate, D-glucose and ethylene glycol to reduce Ag+ to silver nanoparticles. Weighed quantities of cellulose sample ~1 % (w/w) is dispersed in ImM aqueous silver nitrate solution in a beaker and sonicated for half an hour. Aqueous solution of the reducing agents ~ 2-5 mM are added drop wise to the cellulose solution. The reactions are carried out at room temperature except in the case of sodium borohydride where ice- cold condition is maintained and in case of D-glucose, tri-sodium citrate and ethylene glycol, the solution is refluxed for an hour. In case of hydroxyl ammonium hydrochloride as reducing agent, 1 mM alkalinity is maintained by adding aqueous NaOH solution.
Silver nanoparticles loading on cellulose papers: In order to load silver nanoparticles on cellulose papers, the paper is soaked in ImM aqueous silver nitrate solution for half an hour, washed with ethanol and water again soaked in ImM aqueous solutions of reducing agent (hydrazanium hydroxide or sodium borohydride) for half an hour. Finally they were washed with ethanol and water and dried in air at room temperature (-22 0C).
Measurements: Uv-vis absorption measurements were done by using a Perkin-Elmer
Lambda 900 UV/VIS/NIR spectrophotometer. Transmission electron microscopy (TEM) experiments were performed using JEOL 3010 with an operating voltage of 300 keV. Field Emission Scanning Electron Microscopy (FE-SEM) was done by using a Nova 600 NanoSEM (FEI, Germany). The composition mainly carbon, oxygen and silver of silver loaded cellulose were determined by using EDAX equipped to the FE- SEM. The pH measurements were done by using a Eutech pH 510. All the measurements were performed at room temperature (~22 0C).
Assay for antibacterial activity of silver nanocomposite: The antibacterial activity of silver-cellulose nanocomposite was tested using Staphylococcus aureus. A fresh culture of the bacterium was prepared by inoculating a loop of inoculum into 50 ml of nutrient broth and BHI broth. The organism was monitored as 25% glycerol store in broth and was stored at 85 0C. After incubating the culture at 37 0C for 15-20 hrs, serial dilution
in the range 10'1 - 103 was made in 2 ml eppendorf tubes with sterile distilled water. Tryptic soy agar plates were prepared by adding 7.5g of tryptic soy broth medium and 0.2g of agar in 250ml of distilled water. After autoclaving at 20 psi for 15 minutes the molter was pored into disposal petriplates at the rate of 15 ml / dish. After solidification of the medium under aseptic conditions 100 μl of 10"3 dilution Staphylococcus aureus culture was spread into each plate with a glass spreader. Wells were made with the help of a 7 mm cylindrical metal pipe. At the center of the well 50 μl of silver nanocomposite in solution form was placed. The petridishes were kept at 5 0C ± 2 in refrigerator for 2.0 - 2.5 hours. The plates were finally kept 37 0C for 20-24 hours in a BOD incubator. The zone and inhibition is reported as radius from the centre of the well under observation.
Preparation Of Fe3O4 core and Ag shell Nanoparticles:
Materials: All the chemicals AgNO3 (Qualigens, 99.8%), N2H5OH (Merck, ~ 100%), FeCl2.4H2O (NP Chem), anhydrous FeCl3 (Qualigens, 96.0%), HCl (Laboratory
Rasayan, 35-38%), NaOH (Merck, 97%), HNO3 (Laboratory Rasayan, 69-72 %), 2-
Napthalenethiol (Aldrich, 99%), Rhodamine 6G (SD fine chemicals, India, 95%) and
Rhodamine B (SD fine chemicals, India, 80%) were used without further purification.
Millipore water was used to make the solutions. Synthesis: The synthesis of γ - Fe2O3 nanoparticles is done following the procedures described in literature. In a typical synthetic method 25 ml. of aqueous solution containing 0.4 M Fe2+, 0.8 M Fe3+ and 0.4 M HCl is added drop wise to a moderately heated (~50 0C) 250 ml of aqueous 1.5 M NaOH solution under vigorous non-magnetic stirring. A black precipitate of Fe3O4 is formed immediately. After 15 minutes of stirring the precipitates are allowed to settle down, washed with water and magnetically separated. The precipitates are centrifuged at 6000 rpm and then washed twice with water and redispersed in 500 ml water.
By using hydrazanium hydroxide as reducing agent to coat Ag On Fe3O4. 2 ml (containing 0.12 mmol of Fe) of stock solution of Fe3O4 is dispersed in 8 ml of water.
1 % aqueous solution of AgNO3 is added to the solution to make appropriate concentration OfAg+ in the solutions. Five set of concentrations, 10"4, 5 x 10"4, 10"4, 5 x
10~3 and 10"2 M each for Ag+ was done. After 15 minutes 0.2 M aqueous solution of hydrazanium hydroxide is added drop wise with constant shaking. The final concentration of hydrazanium hydroxide is maintained two times higher than Ag+. The solution turns to yellowish green for Ag. The particles are separated by using a magnet and washed 2-3 times with distilled water and finally they were dried under vacuum at room temperature for further characterization.
Fe3U4 core and silver shell (core-shell) nanoparticles loading on cellulose fibers: In order to synthesize cellulose fibers core-shell nanocomposites we have mixed the nanoparticles of Fe3O4 with cellulose fibers and reduced the silver on to the iron oxide nanoparticles as described in the earlier section.
Measurements: Transmission electron microscopy (TEM) images were recorded by using JEOL 3010 with an operating voltage of 300 keV. Uv-Vis absorption measurements were done by using a Perkin-Elmer Lambda 900 UV/VIS/NIR spectrophotometer. The molar ratios of Fe to Ag were determined by EDAX measurements. Magnetization measurements were performed using a VSM in PPMS (Physical property measurement system) with magnetic fields up to 20 kOe at 298.15 K.
Assay for antibacterial activity of silver nanocomposite: The antibacterial activity of core-shell-cellulose nanocomposite was tested using Staphylococcus aureus. A fresh culture of the bacterium was prepared by inoculating a loop of inoculum into 50 ml of nutrient broth and BHI broth. The organism was monitored as 25% glycerol store in broth and was stored at 85 0C. After incubating the culture at 37 0C for 15-20 hrs, serial dilution in the range 10"1 - 103 was made in 2 ml eppendorf tubes with sterile distilled water. Tryptic soy agar plates were prepared by adding 7.5g of tryptic soy broth medium and 0.2g of agar in 250ml of distilled water. After autoclaving at 20 psi for 15 minutes the molter was poured into disposal petriplates at the rate of 15 ml / dish. After solidification of the medium under aseptific conditions 100 μl of 10"3 dilution
Staphylococcus aureus culture was spread into each plate with a glass spreader. Wells were made with the help of a 7 mm cylindrical metal pipe. At the center of the well 50 μl of silver nanocomposite in solution form was placed. The petridishes were kept at 5
0C ± 2 in refrigerator for 2.0 - 2.5 hours. The plates were finally kept 37 0C for 20-24
hours in a BOD incubator. The zone and inhibition is reported as radius from the centre of the well under observation.
Claims
1. Nanoparticle composition comprising cellulose nanofibers embedded with nanosized material.
2. The nanoparticle composition as claimed in claim 1, wherein the cellulose fibers is in the form of paper.
3. The nanoparticle composition as claimed in claim 1, wherein the nanosized material is selected from a group comprising metal and iron oxide embedded metal.
4. The nanoparticle composition as claimed in claim 3, wherein the metal is silver.
5. The nanoparticles composition as claimed in claim 3, wherein the iron oxide is selected from a group comprising Fe3O4, 7-Fe2O3, preferably Fe3O4.
6. The nanoparticle composition as claimed in claim 4, wherein the silver is sourced from a group comprising silver nitrate, silver chloride, silver carbonate, preferably silver nitrate or any combination thereof.
7. The nanoparticles composition as claimed in claim 1, wherein the nanoparticles composition is antibacterial in nature.
8. A method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: a) Mixing metal salt solution with cellulose nanofibers; and b) adding reducing agent to the mixture to reduce the metal salt to obtain said nanoparticles composition.
9. The method as claimed in claim 8, wherein the nanosized material is a metal.
10. The method as claimed in claim 8, wherein the metal salt solution and cellulose nanofibers are mixed by sonication for about 30 min.
11. A method of preparation of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: a) adding metal salt solution to a mixture of cellulose nanofibers and iron oxide; b) reducing metal salt using reducing agent; c) separating the silver embedded iron oxide on cellulose nanofibers; and d) washing with water followed by drying to obtain said nanoparticles composition.
12. The method as claimed in claim 11, wherein the nanosized material is iron oxide embedded metal
13. The method as claimed in claim 11, wherein the silver embedded iron oxide on cellulose nanofibers are separated by magnetic separation.
14. A method of preparation of nanoparticles composition comprising cellulose nanofibers embedded with nanosized material, said method comprising steps of: a) soaking cellulose papers in metal salt solution; b) washing the soaked cellulose paper; c) soaking the washed cellulose papers in solution of reducing agent; d) washing the cellulose papers of step c; and e) drying to obtain said nanoparticles composition.
15. The method as claimed in claim 14, wherein the cellulose fibers is in the paper form.
16. The method as claimed in claim 14, wherein the nanosized material is a metal.
17. The method as claimed in claim 14, wherein the cellulose papers are soaked in metal salt solution for about 30 min.
18. The method as claimed in claim 14, wherein the metal salt solution is about
1 mM solution in concentration.
19. The method as claimed in claim 14, wherein the cellulose papers are washed with mixture ethanol and water, wherein the concentration of ethanol ranges from about 75% to about 85%
20. The method as claimed in claim 14, wherein the reducing agent is selected from a group comprising hydrazanium hydroxide and sodium borohydride.
21. The method as claimed in claim 14, wherein the drying is carried out- at a temperature ranging from about 20 0C to a temperature of about 30 0C preferably 25° C.
22. The method as claimed in claims 8, 11 and 14, wherein the metal is silver.
23. The method as claimed in claims 8, 1 1 and 14, wherein the metal salt is selected from a group comprising silver nitrate, silver chloride, silver carbonate preferably silver nitrate or combination thereof.
24. The method as claimed in claims 8, 11 and 14 wherein the metal salt solution is prepared by dissolving metal salt in water.
25. The method as claimed in claims 8, 11 and 14 wherein the reducing agent is added dropwise with constant stirring to the mixture.
26. The method as claimed in claims 8 and 11 wherein the reducing agent is selected from a group comprising hydrazanium hydroxide, sodium borohydride, hydroxyl ammonium hydrochloride and tri-sodium citrate, preferably hydrazanium hydroxide.
27. The method as claimed in claim 8 and 11 wherein the preparation of nanoparticle composition is carried out at a temperature ranging from about 20 0C to a temperature of about 30 0C preferably 25 0C, when the reducing agent is hydrazanium hydroxide.
28. The method as claimed in claim 8 and 11 wherein the preparation of nanoparticle composition is carried out at a temperature ranging from about 200C to a temperature of about 30 0C preferably 25°C, when the reducing agent is sodium borohydride.
29. The method as claimed in claim 8 and 11 wherein the preparation of nanoparticle composition is carried out at a temperature ranging from about 200C to a temperature of about 300C preferably 25°C, when the reducing agent is tri-sodium citrate.
30. The method as claimed in claims 8 and 1 1 wherein the preparation of nanoparticle composition is carried out at a temperature ranging from about 20
0C to a temperature of about 30 0C preferably 25 0C, when the reducing agent is hydroxyl ammonium hydrochloride.
31. The method as claimed in claims 8 and 11 wherein the preparation of nanoparticle composition is carried out by maintaining about ImM alkalinity by adding sodium hydroxide solution when the reducing agent is hydroxyl ammonium hydrochloride.
32. Use of nanoparticle composition comprising cellulose nanofibers embedded with nanosized material in the manufacture of antibacterial medicament.
33. The use as claimed in claim 32, wherein the medicament is used in food packaging, clothing, medical applications, face masks, laundry detergent and air filters.
34. The use as claimed in claim 33, wherein the medical applications is selected i from a group comprising wound coverings, dressings, bandages, biological implants, and diagnostic biomedical optical imaging.
35. The use as claimed in claim 32, wherein the nanoparticle composition is nontoxic and free from side effects.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/739,395 US8834917B2 (en) | 2007-11-13 | 2008-11-14 | Nanoparticle composition and process thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN02628/CHE/2007 | 2007-11-13 | ||
IN2628CH2007 | 2007-11-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009063508A2 true WO2009063508A2 (en) | 2009-05-22 |
WO2009063508A3 WO2009063508A3 (en) | 2009-07-23 |
Family
ID=40639294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2008/000771 WO2009063508A2 (en) | 2007-11-13 | 2008-11-14 | Nanoparticle composition and process thereof |
Country Status (2)
Country | Link |
---|---|
US (1) | US8834917B2 (en) |
WO (1) | WO2009063508A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2643021A1 (en) * | 2010-11-23 | 2013-10-02 | FPInnovations | Binding drugs with nanocrystalline cellulose (ncc) |
US8569063B1 (en) | 2011-04-08 | 2013-10-29 | Western Kentucky University Research Foundation | Planta gold nanoparticle manufacture |
WO2014009517A1 (en) * | 2012-07-13 | 2014-01-16 | Sappi Netherlands Services B.V. | Low energy method for the preparation of non-derivatized nanocellulose |
WO2014198352A1 (en) * | 2013-06-10 | 2014-12-18 | Instytut Chemii Fizycznej Polskiej Akademii Nauk | Method for surface modification with nanocomposites, nanocomposite material and the use thereof |
JP2015218421A (en) * | 2014-05-21 | 2015-12-07 | 凸版印刷株式会社 | Porous body and manufacturing method thereof, and heat insulation film |
WO2016045795A1 (en) * | 2014-09-25 | 2016-03-31 | Borregaard As | Pesticide compositions and use thereof |
CZ307996B6 (en) * | 2016-01-27 | 2019-10-09 | Univerzita Palackého v Olomouci | Polymer substrate with immobilized silver nanoparticles and preparing it |
CN110951444A (en) * | 2019-11-11 | 2020-04-03 | 南通市开泰高分子材料有限公司 | Intranet type silicone sealant for building and preparation method thereof |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI123988B (en) | 2010-10-27 | 2014-01-31 | Upm Kymmene Corp | Cell Culture Materials |
WO2012177247A2 (en) * | 2011-06-22 | 2012-12-27 | Empire Technology Development Llc | Non-covalently bonding anti-microbial nanoparticles for water soluble wood treatment |
US8951611B2 (en) | 2011-07-11 | 2015-02-10 | Empire Technology Development Llc | Methods and compositions for treating wood |
WO2013012421A2 (en) | 2011-07-20 | 2013-01-24 | Empire Technology Development Llc | Compositions and methods for making glass fortified wood |
SE536780C2 (en) | 2011-10-26 | 2014-08-05 | Stora Enso Oyj | Process for preparing a dispersion comprising nanoparticles and a dispersion prepared according to the process |
US20130330417A1 (en) * | 2012-06-08 | 2013-12-12 | U.S. Army Research Laboratory Attn: Rdrl-Loc-I | Nanocellulose foam containing active ingredients |
FI125965B (en) | 2012-09-25 | 2016-04-29 | Upm Kymmene Corp | Three-dimensional cell culture |
GB2511528A (en) | 2013-03-06 | 2014-09-10 | Speciality Fibres And Materials Ltd | Absorbent materials |
FI126837B (en) * | 2013-09-05 | 2017-06-15 | Upm Kymmene Corp | Composite articles and process for its manufacture |
JP6248511B2 (en) * | 2013-09-30 | 2017-12-20 | 凸版印刷株式会社 | Thickening and coloring antibacterial agent, method for producing the same, and composition for personal care products |
CN104005303A (en) * | 2014-06-13 | 2014-08-27 | 广东轻工职业技术学院 | Nano-silver composite antibacterial paper, making method thereof and application of nano-silver composite antibacterial paper |
WO2016130554A1 (en) | 2015-02-09 | 2016-08-18 | Osinski Marek A | Methods and compositions for antimicrobial treatment |
JP6895991B2 (en) * | 2016-01-12 | 2021-06-30 | カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ | Nanobiocomposite preparation for wound healing and its preparation method |
EP3351105A1 (en) * | 2017-01-20 | 2018-07-25 | Kauno Technologijos Universitetas | Silicone materials having antimicrobial efficiency |
CN109093110B (en) * | 2017-06-20 | 2021-09-07 | 华邦电子股份有限公司 | Composite material and method for producing same |
US20200337301A1 (en) * | 2017-07-30 | 2020-10-29 | IMI Tami Institute for Research and Development ltd | Antimicrobial coating material comprising nanocrystalline cellulose and magnesium oxide and method of preparation thereof |
CN110982098B (en) * | 2019-05-24 | 2022-05-17 | 陕西师范大学 | Tin/protein nano hybrid membrane and application thereof |
US20210062411A1 (en) * | 2019-08-30 | 2021-03-04 | The United States Of America, As Represented By The Secretary Of Agriculture | Cellulosic fibers comprising embedded silver nanoparticles and uses therof |
CN110680809A (en) * | 2019-11-28 | 2020-01-14 | 东南大学 | Oral nano iron supplement and preparation method thereof |
CN112458751A (en) * | 2020-09-15 | 2021-03-09 | 鲁东大学 | Nano-silver para-aramid fiber, and preparation method and application thereof |
CN114051368A (en) * | 2021-06-16 | 2022-02-15 | 南通大学 | Loofah fiber electromagnetic wave absorbing material and preparation method thereof |
CN113521304B (en) * | 2021-07-09 | 2023-12-12 | 华南理工大学 | Dual-curative-effect anti-tumor drug based on nanocellulose load and preparation method thereof |
CN114277614A (en) * | 2022-01-04 | 2022-04-05 | 吉林大学 | Oxide material with plasmon resonance performance and antibacterial packaging application |
CN115054691A (en) * | 2022-07-15 | 2022-09-16 | 中山大学附属第七医院(深圳) | Ternary sulfur group metal nano particle and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003063996A2 (en) * | 2002-01-31 | 2003-08-07 | Koslow Technologies Corporation | Precoat filtration media and methods of making and using |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10225324A1 (en) * | 2002-06-06 | 2003-12-18 | Itn Nanovation Gmbh | Production of antimicrobial varnish, e.g. for long-term protection of door handles and sanitary fittings, involves modifying varnish by adding nano-particles with a silver- or copper-enriched surface |
US20070292469A1 (en) * | 2005-07-25 | 2007-12-20 | Rothenburger Stephen J | Antimicrobial composition |
-
2008
- 2008-11-14 US US12/739,395 patent/US8834917B2/en not_active Expired - Fee Related
- 2008-11-14 WO PCT/IN2008/000771 patent/WO2009063508A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003063996A2 (en) * | 2002-01-31 | 2003-08-07 | Koslow Technologies Corporation | Precoat filtration media and methods of making and using |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2643021A4 (en) * | 2010-11-23 | 2014-11-05 | Fpinnovations | Binding drugs with nanocrystalline cellulose (ncc) |
EP2643021A1 (en) * | 2010-11-23 | 2013-10-02 | FPInnovations | Binding drugs with nanocrystalline cellulose (ncc) |
US8569063B1 (en) | 2011-04-08 | 2013-10-29 | Western Kentucky University Research Foundation | Planta gold nanoparticle manufacture |
EA025803B1 (en) * | 2012-07-13 | 2017-01-30 | Саппи Нидерландс Сервисез Б.В. | Low energy method for the preparation of non-derivatized nanocellulose |
CN104470951A (en) * | 2012-07-13 | 2015-03-25 | 赛佩荷兰服务有限公司 | Low energy method for the preparation of non-derivatized nanocellulose |
US9371401B2 (en) | 2012-07-13 | 2016-06-21 | Sappi Netherlands Services B.V. | Low energy method for the preparation of non-derivatized nanocellulose |
WO2014009517A1 (en) * | 2012-07-13 | 2014-01-16 | Sappi Netherlands Services B.V. | Low energy method for the preparation of non-derivatized nanocellulose |
AU2013288608B2 (en) * | 2012-07-13 | 2017-08-03 | Sappi Netherlands Services B.V. | Low energy method for the preparation of non-derivatized nanocellulose |
WO2014198352A1 (en) * | 2013-06-10 | 2014-12-18 | Instytut Chemii Fizycznej Polskiej Akademii Nauk | Method for surface modification with nanocomposites, nanocomposite material and the use thereof |
JP2015218421A (en) * | 2014-05-21 | 2015-12-07 | 凸版印刷株式会社 | Porous body and manufacturing method thereof, and heat insulation film |
WO2016045795A1 (en) * | 2014-09-25 | 2016-03-31 | Borregaard As | Pesticide compositions and use thereof |
CZ307996B6 (en) * | 2016-01-27 | 2019-10-09 | Univerzita Palackého v Olomouci | Polymer substrate with immobilized silver nanoparticles and preparing it |
CN110951444A (en) * | 2019-11-11 | 2020-04-03 | 南通市开泰高分子材料有限公司 | Intranet type silicone sealant for building and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2009063508A3 (en) | 2009-07-23 |
US8834917B2 (en) | 2014-09-16 |
US20100233245A1 (en) | 2010-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8834917B2 (en) | Nanoparticle composition and process thereof | |
Munnawar et al. | Synergistic effect of Chitosan-Zinc Oxide Hybrid Nanoparticles on antibiofouling and water disinfection of mixed matrix polyethersulfone nanocomposite membranes | |
Rahmati et al. | Ag-doped magnetic metal organic framework as a novel nanostructured material for highly efficient antibacterial activity | |
JP6423833B2 (en) | Composition and method of antibacterial metal nanoparticles | |
Buşilă et al. | Synthesis and characterization of antimicrobial textile finishing based on Ag: ZnO nanoparticles/chitosan biocomposites | |
Zhou et al. | Synthesis and characterization of silver nanoparticles-doped hydroxyapatite/alginate microparticles with promising cytocompatibility and antibacterial properties | |
Avcu et al. | Biodegradable polymer matrix composites containing graphene-related materials for antibacterial applications: A critical review | |
Shahidi et al. | Antibacterial agents in textile industry | |
JP5777337B2 (en) | Antibacterial material | |
Elbarbary et al. | Radiation synthesis and characterization of polyvinyl alcohol/chitosan/silver nanocomposite membranes: antimicrobial and blood compatibility studies | |
Rathod et al. | Synthesis of monodispersed silver nanoparticles by Rhizopus stolonifer and its antibacterial activity against MDR strains of Pseudomonas aeruginosa from burnt patients | |
Martynková et al. | Antimicrobial nanocomposites based on natural modified materials: a review of carbons and clays | |
Anghel et al. | Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development | |
CN105776179B (en) | A kind of water soluble quaternary ammonium salinization Nano carbon balls and preparation method and application | |
Wang et al. | Vancomycin-modified Fe3O4@ SiO2@ Ag microflowers as effective antimicrobial agents | |
Vo et al. | Silver deposited carboxymethyl chitosan-grafted magnetic nanoparticles as dual action deliverable antimicrobial materials | |
Wang et al. | Silver nanoparticle and lysozyme/tannic acid layer-by-layer assembly antimicrobial multilayer on magnetic nanoparticle by an eco-friendly route | |
Jagadeeshan et al. | Nano-metal oxides for antibacterial activity | |
Zhang et al. | In situ assembly of well-dispersed Ag nanoparticles on the surface of polylactic acid-Au@ polydopamine nanofibers for antimicrobial applications | |
Shan et al. | Flexible, mesoporous, and monodispersed metallic cobalt-embedded inorganic nanofibrous membranes enable ultra-fast and high-efficiency killing of bacteria | |
Huang et al. | In situ green synthesis of antimicrobial carboxymethyl chitosan–nanosilver hybrids with controlled silver release | |
Pal et al. | In situ generation and deposition of ZnO nanoparticles on cotton surface to impart hydrophobicity: investigation of antibacterial activity | |
Wang et al. | Ultra-fast bacterial inactivation of Cu2O@ halloysite nanotubes hybrids with charge adsorption and physical piercing ability for medical protective fabrics | |
Nawab et al. | Review featuring the use of inorganic nano-structured material for anti-microbial properties in textile | |
Wang et al. | In situ synthesis of silver or selenium nanoparticles on cationized cellulose fabrics for antimicrobial application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08849057 Country of ref document: EP Kind code of ref document: A2 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 12739395 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08849057 Country of ref document: EP Kind code of ref document: A2 |